Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Tolerability, Efficacy and Pharmacokinetics of AK3280 Cream in Patients With Hypertrophic Scar Excision
CTR20220666Phase 2Completed
- Sponsor
- Ark Biosciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AK3280 in Hypertrophic Scar (HS), sponsored by Ark Biosciences. Started Mar 2022; status: completed.
02
Drugs
AK3280
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on CTR20220666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220666.